Griseofulvin-induced hepatopathy due to abnormalities in heme pathways

1. The effect of long term griseofulvin (GRIS) topical administration on some indica tors of liver damage was examined. 2. Liver porphyrin accumulation was significant; however, no porphyrin crystals were observed under light microscopy, 3. An earlier onset of hepatopathy was established (3-fold) in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Polo, C.F
Otros Autores: Buzaleh, A.M, Vazquez, E.S, Afonso, S.G, Navone, N.M, Del Carmen Batlle, A.M
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1997
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 09515caa a22011657a 4500
001 PAPER-3215
003 AR-BaUEN
005 20230518203241.0
008 190411s1997 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0030807203 
024 7 |2 cas  |a Antibiotics, Antifungal; Biological Markers; Griseofulvin, 126-07-8; Heme, 14875-96-8 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a GEPHD 
100 1 |a Polo, C.F. 
245 1 0 |a Griseofulvin-induced hepatopathy due to abnormalities in heme pathways 
260 |c 1997 
270 1 0 |m Del Carmen Batlle, A.M.Viamonte 1881, 1056 Buenos Aires, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Avner, D.L., Berenson, M.M., Hepatic clearance and biliary secretion of protoporphyrin in the isolated in situ perfused rat liver (1982) J. Lab. Clin. Med., 99, pp. 885-894 
504 |a Avner, D.L., Berenson, M.M., Effect of choleretics on canalicular transport of protoporphyrin in rhe rat liver (1982) Am. J. Physiol., 242, pp. 347-353 
504 |a Avner, D.L., Lee, R.C., Berenson, M.M., Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver (1981) J. Clin. Invest., 67, pp. 385-394 
504 |a Avner, D.L., Larsen, R., Berenson, M.M., Inhibition of liver surface membrane Na, K-adenosine triphosphatase, Mg-adenosine triphosphatase and 5′-nucleotidase activities by protoporphyrin. Observations in vitro and in the perfused rat liver (1983) Gastroenterology, 85, pp. 700-706 
504 |a Bloomer, J.R., The liver in protoporphyria (1988) Hepatology, 8, pp. 402-407 
504 |a Bonkowsky, H.L., Key relationships of hepatic heme and iron metabolism: New insights into functions of two old molecules (1991) Viewpoints Digest. Dis., 23, pp. 19-26 
504 |a Cantoni, L., Di Padova, C., Rovagnati, P., Ruggieri, R., Dal Fiume, D., Tritapepe, R., Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria (1983) Toxicology, 27, pp. 27-39 
504 |a De Matteis, F., Hepatic porphyrias caused by 2-allyl-2-isopropylacetamide, 3,5-diethoxycarbonyl-1,4-dihydro-collidine, griseofulvin and related compounds (1978) Handbook of Experimental Pharmacology, 44, pp. 129-155. , (Edited by De Matteis F., and Aldridge W. N.) Springer, Berlin 
504 |a De Matteis, F., Gibbs, A., Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-diethoxycarbonyl-1,4-dihydrocollidine and related drugs (1975) Biochem. J., 146, pp. 285-287 
504 |a De Matteis, F., Donnelly, A.J., Runge, W.J., The effect of prolonged administration of griseofulvin in mice with reference to sex differences (1966) Cancer Res., 26, pp. 721-726 
504 |a Denk, H., Kalt, M., Abdelfattah-Gad, M., Meyer, U.A., Effect of griseofulvin on 5-aminolevulinate synthase and on ferrochelatase in mouse liver neoplastic nodules (1981) Cancer Res., 41, pp. 1535-1538 
504 |a Gschnait, F., Konrad, K., Honigsmann, H., Denk, H., Wolff, K., Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals (1975) J. Invest. Dermatol., 65, pp. 290-299 
504 |a Ibraham, N.G., Friedland, M.L., Levere, R.D., Heme metabolism in erythroid and hepatic cells (1983) Prog. Hematol., 13, pp. 75-130 
504 |a Koller, M.E., Romslo, I., Uptake of protoporphyrin by isolated rat liver mitochondria (1980) Biochem J., 188, pp. 329-335 
504 |a Koningsberger, J.C., (1992) The Dark Side of Protoporphyria, , Doctoral Thesis, Utretch, The Netherlands 
504 |a Lefkowitch, J.H., Feng-Cheng, K.C., Sklar, J.A., Poh-Fitzpatrick, M.B., Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria (1983) Hepatology, 3, pp. 399-406 
504 |a Macdonald, D.M., Germain, D., Perrot, H., The histopathology and ultrastructure of liver disease in erythropoietic protoporphyria (1981) Br. J. Dermatol., 104, pp. 7-17 
504 |a Morton, K.O., Schneider, F., Weimer, M.K., Straka, J.G., Bloomer, J.R., Hepatic and bile porphyrins in protoporphyria and liver failure (1988) Gastroenterology, 94, pp. 1488-1492 
504 |a (1985) Guide for the Care and Use of Laboratory Animals, , NIH Publication No. 86-23. NIH, Bethesda 
504 |a Navone, N.M., Buzaleh, A.M., Polo, C.F., Afonso, S.G., Vazquez, E.S., Batlle, A., The effect of griseofulvin on the heme pathway-II. An exhaustive analysis during short and long-term challenge (1991) Gen. Pharmacol., 22, pp. 1179-1183 
504 |a Polo, C.F., Frisardi, A.L., Resnik, E., Schoua, A.E., Batlle, A., Factors influencing fluorescence spectra of free porphyrins (1988) Clin. Chem., 34, pp. 757-760 
504 |a Rademakers, L.H.P.M., Cleton, M.I., Kooijman, C., Baart De La Faille, H., Van Hattum, J., Early involvement of hepatic parenchymal cells in erythropoietic protoporphyria? an ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment (1990) Hepatology, 11, pp. 449-457 
504 |a Schacter, B.A., Heme catabolism by heme oxygenase: Physiology, regulation and mechanism of action (1988) Sem. Hematol., 25, pp. 349-369 
504 |a Schacter, B.A., Firneisz, J.E., Effect of cholestasis produced by bile duct ligation on hepatic heme and hemoprotein metabolism in rats (1983) Gastroenterology, 84, pp. 227-235 
504 |a Singer, J.A., Plaut, A.G., Kaplan, M.M., Hepatic failure and death from erythropoietic protoporphyria (1978) Gastroenterology, 74, pp. 588-591 
504 |a Vazquez, E.S., Afonso, S.G., Buzaleh, A.M., Navone, N.M., Polo, C.F., Schoua, A.E., Batlle, A., The effect of griseofulvin on the heme pathway. Studies on tissue explant cultures (1987) Toxicology, 46, pp. 73-82 
504 |a Vlahcevic, Z.R., Heuman, D.M., Hylemon, P.B., Regulation of bile acid synthesis (1991) Hepatology, 13, pp. 590-600 
504 |a Weston-Hurst, E., Paget G, E., Protoporphyrin cirrhosis and hepatomata in the livers of mice given griseofulvin (1963) Br. J. Dermatol., 75, pp. 105-112 
520 3 |a 1. The effect of long term griseofulvin (GRIS) topical administration on some indica tors of liver damage was examined. 2. Liver porphyrin accumulation was significant; however, no porphyrin crystals were observed under light microscopy, 3. An earlier onset of hepatopathy was established (3-fold) increase of direct bilirubin values after 7 days of treatment; hepatic injury was confirmed by measuring a g fold increase of free bilirubin. 4. Enhanced values of alkaline phosphatase and glutamic oxalacetic transaminase (GOT) confirmed the onset of cholestasis. 5. Topical application of GRIS induced measurable hepatopathy. Nevertheless, we cannot discard the possibility that this hepatopathy could also be attributed in part to a direct reaction to xenobiotics.  |l eng 
536 |a Detalles de la financiación: Ministry of Education and Science 
536 |a Detalles de la financiación: versity of Buenos Aires, and of the Spanish Ministry of Education and Science is gratefully acknowledged. We are indebted to Lic. E. Gerez for the preparation of the liver samples usedin microscopic studies and to Dr. E. Falzoni for the histological analysis. We also are grateful to Mrs. Beatriz Corvaldn for her skilled technical assistance. 
593 |a Natl. Res. Ctr. Porphyrins P., FCEN (UBA), CONICET, Buenos Aires, Argentina 
690 1 0 |a CHOLESTASIS 
690 1 0 |a GRISEOFULVAN 
690 1 0 |a HEME PATHWAY 
690 1 0 |a HEPATOPATHY 
690 1 0 |a ALKALINE PHOSPHATASE 
690 1 0 |a ASPARTATE AMINOTRANSFERASE 
690 1 0 |a BILIRUBIN 
690 1 0 |a BILIRUBIN GLUCURONIDE 
690 1 0 |a GRISEOFULVIN 
690 1 0 |a HEME 
690 1 0 |a PORPHYRIN 
690 1 0 |a XENOBIOTIC AGENT 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL TISSUE 
690 1 0 |a ARTICLE 
690 1 0 |a CHOLESTASIS 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a LIVER DISEASE 
690 1 0 |a LIVER INJURY 
690 1 0 |a LIVER LEVEL 
690 1 0 |a LONG TERM EXPOSURE 
690 1 0 |a MALE 
690 1 0 |a MICROSCOPY 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a TOPICAL DRUG ADMINISTRATION 
690 1 0 |a ADMINISTRATION, TOPICAL 
690 1 0 |a ANIMALS 
690 1 0 |a ANTIBIOTICS, ANTIFUNGAL 
690 1 0 |a BIOLOGICAL MARKERS 
690 1 0 |a GRISEOFULVIN 
690 1 0 |a HEME 
690 1 0 |a LIVER 
690 1 0 |a LIVER FUNCTION TESTS 
690 1 0 |a MALE 
690 1 0 |a MICE 
700 1 |a Buzaleh, A.M. 
700 1 |a Vazquez, E.S. 
700 1 |a Afonso, S.G. 
700 1 |a Navone, N.M. 
700 1 |a Del Carmen Batlle, A.M. 
773 0 |d 1997  |g v. 29  |h pp. 207-210  |k n. 2  |p GEN. PHARMACOL.  |x 03063623  |w (AR-BaUEN)CENRE-4808  |t General Pharmacology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030807203&doi=10.1016%2fS0306-3623%2896%2900406-5&partnerID=40&md5=7dc93e775903142b10c3e504375a7202  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0306-3623(96)00406-5  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_03063623_v29_n2_p207_Polo  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03063623_v29_n2_p207_Polo  |y Registro en la Biblioteca Digital 
961 |a paper_03063623_v29_n2_p207_Polo  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 64168